Director, UCLA Center for HIV Prevention Research (CPR)
Core Director, UCLA Center for AIDS Research (CFAR) Mucosal Immunology Core Laboratory (MICL)
Dr. Anton’s research focuses on the degree of mucosal inflammation and altered co-receptor expression associated with HIV infection and associated therapeutic interventions, the potential use of the mucosa as a route of HIV immunization with various HIV vaccine candidates as well as microbicides for HIV mucosal prevention, investigating the interaction of HSV and HIV in mucosal pathogenesis and efforts to clarify the role of compartments in HIV pathogenesis.
Vice-Chief, Vatche and Tamar Manoukian Division of Digestive Diseases
Program Director, UCLA GI Fellowship Training Program
Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience
Director, UCLA Center for Excellence in Pancreatic Diseases Editor-in-Chief, Pancreas
Dr. Go began his academic career at Mayo Clinic over four decades ago, investigating the regulation of human exocrine and endocrine pancreas in health and diseases; subsequently, expanded towards nutrition, altered metabolism, and cancer prevention. His current research focuses on phytonutrient mechanism of action; utilizing molecular biology and metabolomic technologies. He is currently the director of NIH/NCCAM funded UCLA Center for Excellence in Pancreatic Diseases and the editor-in-chief of Pancreas.
G. Oppenheimer Center for Neurobiology of Stress and Resilience Adjunct Assistant Professor
Dr. Gupta completed a PhD degree in psychology from the University of Tennessee, Knoxville, followed by an APA accredited clinical internship at Massachusetts General Hospital/Harvard Medical Center. Her programmatic line of research broadly defined focuses on the bidirectional interactions between the brain and peripheral factors (in particular inflammatory markers and gut microbiota-related metabolites) and how these interactions are modified by vulnerability (early adversity, race, adult stress, socioeconomic status [SES], diet) and protective environmental (resilience, exercise) factors in contributing to the underlying pathophysiology of obesity.
Director, Center for Systems Biomedicine
Director, Iliopoulos Laboratory
Dr. Iliopoulos performed his undergraduate studies in the Department of Biology at the Aristotelian University of Thessaloniki in Greece. He performed his PhD studies in the Integrative Biomedical Science Graduate Program at Ohio State University and graduated at 2006.
Director, Jacobs Laboratory
Dr. Jacobs graduated magna cum laude with highest honors from Harvard University with an AB in biochemistry. He subsequently received his MD from Harvard Medical School, graduating magna cum laude in a special field.
Director, Hemostasis Program
Director, NIH GI Training Grant
Associate Director, UCLA CURE: Digestive Diseases Research Center
Dr. Jensen earned his medical degree at the University of Washington Medical School in Seattle. He completed a medical internship and first-year medical residency at University of Oregon and Affiliated Hospitals.
Center for Systems Biomedicine
Dr. Karagiannidis received his bachelor’s degree in biology at Plymouth State University and his master’s degree in genetics at University of New Hampshire. He went on to study in the Department of Pathology and Laboratory Medicine at Boston University School of Medicine.
Center for Inflammatory Bowel Diseases
Dr. Koon’s research is focused on the roles of antimicrobial peptide cathelicidin in inflammatory bowel disease, intestinal infection, colon cancer, obesity, and diabetes.
Director, Esophageal Physiology Program for the Center for Esophageal Disorders
Dr. Kovacs graduated from McGill University and completed his internal medicine residency, chief medical residency, and gastroenterology fellowship at the Royal Victoria Hospital in Montreal.
Director, Neuroimaging and Bioinformatics Core, G. Oppenheimer Center for Neurobiology of Stress and Resilience
Dr. Labus is an investigator and director for the Neuroimaging and Bioinformatics Core in the G. Oppenheimer Center for Neurobiology of Stress and Resilience at UCLA. Her research is focused on the interface of stress, pain and emotions and its influence on the role of dysregulation in the pathophysiology of common chronic pain disorders.
Adjunct Associate Professor
Dr. Marvizón’s research field is the neurophysiology of pain and analgesia. His overall research goal is investigating cellular and molecular mechanisms that mediate central sensitization in the spinal cord.
Co-Director, Global Health Education Program
Dr. May graduated cum laude from Yale University with a degree in molecular, cellular, and developmental biology. After college, she attended the University of Cambridge to study epidemiology and international health, earning a masters of philosophy before returning to the States to attend Harvard Medical School.
Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience
Co-Director, CURE: Digestive Diseases Research Center
Dr. Mayer received is MD/PhD degree from the Ludwig Maximilian’s University in Munich, Germany, did his residency at the Vancouver General Hospital in Vancouver, Canada, and his GI fellowship training at the UCLA/VA Wadsworth Training Program.
Associate Director, Animal Model Core, CURE: Digestive Diseases Research Center
Co-Director, Preclinical Stress Neurobiology Program, Center for Neurovisceral Sciences & Women's Health
Dr. Mulugeta focuses on the role of CRF2 receptors (CRF2R) in stress-related alteration of colonic function and visceral pain. His Neurogastroenterology research program tests the hypothesis that CRFR2 activation modulates stress-related neuroenteric physiology, lower gut motor function alterations and stress-related visceral pain of colonic origin.
Associate Director, UCLA GI Fellowship Program
Director, Padua Laboratory
Dr. Padua received his undergraduate education at the University of Chicago, majoring in biological chemistry and graduating with honors. His interest in the medical sciences led him to apply to the MD/PhD program at Cornell University.
Chief, Division of Gastroenterology, Hepatology and Parenteral Nutrition Veterans Administration Greater Los Angeles Healthcare System, Wadsworth VA
Dr. Pisegna’s main research interest is the molecular pharmacology of hormones and receptors in the gastrointestinal tract.
Director: Basic Research, UCLA Center for Inflammatory Bowel Diseases
Chief for Research Integration
Dr. Pothoulakis’ research program is primarily focused on the role of neuropeptides and hormones in several disease states, including Inflammatory Bowel Disease, Clostridium difficile infection, and Irritable Bowel Syndrome.
Director, CURE Digestive Diseases Research Center
Hirschberg Memorial Chair in Pancreatic Cancer Research
Dr. Rozengurt discovered that neuro-hormonal signals (e.g., peptides of the bombesin family) which act as molecular messengers in a rich network of information exchange throughout the organism via GPCRs, are potent cellular growth factors for multiple cell types in culture, including intestinal epithelial cells and function as autocrine/paracrine mitogens for human cancer cells.
Director, Membrane Biology Laboratory, Veterans Administration Greater LA Healthcare System Professor, Department of Medicine and Physiology, Wilshire Chair of Medicine
Dr. Sachs earned his BSc in biochemistry and MB, ChB in medicine from the University of Edinburgh. He completed his postgraduate studies at Albert Einstein College.
Associate Director CURE: Digestive Diseases Research Center
Director, Morphology and Imaging Core
Chair, CURE Pilot and Feasibility Study Program
Dr. Sternini's research program is focused on transmitter and receptor function and the mechanisms that govern receptor-mediated responses in the enteric nervous system. Her studies have provided the first evidence that µ opioid receptor, the preferred receptor for potent analgesics with severe side effects including the opioid bowel syndrome, undergoes agonist-selective endocytosis upon stimulation in vivo.
Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience
Director, Animal Core, CURE: Digestive Diseases Research Center
Dr. Taché is a recognized leading expert in brain-gut interactions and the role of peptides in the underlying mechanisms of stress-related gut dysfunction. She and her research team reported some of the pioneer work on the central actions of peptides to influence digestive function and feeding behavior. Her laboratory provided the preclinical ground work showing potential benefit of blocking corticotropin releasing signaling pathways in experimental models of irritable bowel syndrome and postoperative ileus. In collaboration with Dr. Lixin Wang she demonstrated the role of ghrelin agonists to alleviate gut motor dysfunction in models of Parkinson Disease.
Co-Director, Neuroimaging Core, G. Oppenheimer Center for Neurobiology of Stress and Resilience
Chief of Integrative Medicine, Greater Los Angeles VA
Dr. Kirsten Tillisch is an associate professor of medicine in the Division of Digestive Diseases and the chief of integrative medicine at the Greater Los Angeles VA.